|
|
12:15-12:30 |
Break |
|
|
12:30-14:45 |
Medication-overuse headache (MOH), (Lunch Seminar; Pfizer) |
|
“Do all analgesics cause MOH and need detoxification?” |
|
Chair:Rapoport A (slide) (ABSTRACT) |
10‘ |
Rapoport A: Overview |
7’ |
Case presentation by a student: Imai N (slide) |
|
What do headache specialists think about the mechanisms and |
|
management of MOH? |
25’ |
Charles A (slide) (ABSTRACT) |
25’ |
Diener C (slide) (ABSTRACT) |
|
|
14:45-15:45 |
Women’s issues in headache medicine (GlaxoSmithKline K.K.) |
|
Chair:Hirata K |
7’ |
Case presentation by a student: Unno Y (slide) |
35’ |
MacGregor A (slide) (ABSTRACT) |
15’ |
Discussion |
|
|
15:45-16:00 |
Break |
|
|
16:00-17:00 |
Integrated approaches at the headache centers (Kyowa-Kirin) |
|
Chair:Kim JM |
40’ |
Integrated approach in preventive medicine: Göbel H (ABSTRACT) |
10’ |
Valproic acid for the prevention of migraine:Schoonman G (ABSTRACT) |
10’ |
Discussion |
|
|
17:00-18:00 |
Procedural medicine |
|
Chair: Diener C |
20’ |
Botulinum Neurotoxin for Chronic Migraine and Trigeminal Neuralgia
:
Dodick D (slide) (ABSTRACT) |
20’ |
Nerve blocks and neurostimulation: Schoenen J (slide) (ABSTRACT) |
20’ |
Discussion on new treatment approaches |
|
|
18:00-18:30 |
General discussion |
|
Chair: Purdy A (slide) (ABSTRACT) |
30’ |
Discussion and Comments on the Master School |
18:30-18:35 |
Concluding remarks: Goadsby P, Sakai F |